ENGLEMAN EDGAR 4
4 · Bolt Biotherapeutics, Inc. · Filed Mar 28, 2022
Insider Transaction Report
Form 4
ENGLEMAN EDGAR
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-03-24+25,000→ 25,000 totalExercise: $3.03Exp: 2032-03-23→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.